Fig. 14
Multi-fusion of three positron emission tomography (PET) images fused with a computed tomography (CT) image of a patient with castrate-resistant metastatic prostate cancer using radiopharmaceuticals: FDHT, FDG, and DCFPyl. FDG, fluorodeoxyglucose; FDHT, fluoro-dihydrotestosterone; and DCFPyl, 18F-piflufolastat